You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 28, 2025

Dr Reddys La Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for DR REDDYS LA

DR REDDYS LA has one hundred and seventy-three approved drugs.

There are twenty-two tentative approvals on DR REDDYS LA drugs.

Summary for Dr Reddys La
US Patents:0
Tradenames:142
Ingredients:122
NDAs:173

Drugs and US Patents for Dr Reddys La

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Inc AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 077183-004 Apr 15, 2010 AB RX No No ⤷  Get Started Free ⤷  Get Started Free
Dr Reddys Labs Ltd CIPROFLOXACIN EXTENDED RELEASE ciprofloxacin; ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 077701-002 Oct 31, 2007 DISCN No No ⤷  Get Started Free ⤷  Get Started Free
Dr Reddys Labs Sa BIORPHEN phenylephrine hydrochloride SOLUTION;INTRAVENOUS 212909-001 Oct 21, 2019 AP RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free
Dr Reddys Labs Sa FENTANYL CITRATE fentanyl citrate TABLET;BUCCAL, SUBLINGUAL 206329-005 Aug 22, 2022 DISCN No No ⤷  Get Started Free ⤷  Get Started Free
Dr Reddys Labs Inc METFORMIN HYDROCHLORIDE metformin hydrochloride TABLET;ORAL 077787-002 Aug 23, 2006 AB RX No No ⤷  Get Started Free ⤷  Get Started Free
Dr Reddys Labs Ltd LANSOPRAZOLE lansoprazole CAPSULE, DELAYED REL PELLETS;ORAL 091269-002 Oct 15, 2010 AB RX No No ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Dr Reddys La

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-006 Nov 12, 1999 4,597,961 ⤷  Get Started Free
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-004 Nov 12, 1999 4,597,961 ⤷  Get Started Free
Dr Reddys Labs Sa TRI-NORINYL 28-DAY ethinyl estradiol; norethindrone TABLET;ORAL-28 018977-002 Apr 13, 1984 4,390,531 ⤷  Get Started Free
Dr Reddys Labs Sa TRI-NORINYL 21-DAY ethinyl estradiol; norethindrone TABLET;ORAL-21 018977-001 Apr 13, 1984 4,390,531 ⤷  Get Started Free
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-005 Nov 12, 1999 5,834,011 ⤷  Get Started Free
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-006 Nov 12, 1999 5,016,652 ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for DR REDDYS LA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.